MED1/TRAP220 exists predominantly in a TRAP/ Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription.

Human TRAP/Mediator is a key coactivator for many transcription factors that act through direct interactions with distinct subunits, and MED1/TRAP220 is the main subunit target for various nuclear receptors. Remarkably, the current study shows that MED1/TRAP220 only exists in a TRAP/Mediator subpopulation (less then 20% of the total) that is ...
greatly enriched in specific TRAP/Mediator subunits and is tightly associated with a near stoichiometeric level of RNA polymerase II. Importantly, this MED1/TRAP220-containing holoenzyme supports both basal- and activator-dependent transcription in an in vitro system lacking additional RNA polymerase II. Furthermore, chromatin immunoprecipitation experiments demonstrate an activator-selective recruitment of MED1/TRAP220-containing versus MED1/TRAP220-deficient TRAP/Mediator complexes to estrogen receptor (ER) and p53 target genes, respectively. Finally, RNAi studies show that MED1/TRAP220 is required for ER-mediated transcription and estrogen-dependent breast cancer cell growth. These observations have significant implications for our current understanding of the composition, heterogeneity, and functional specificity of TRAP/Mediator complexes.
Mesh Terms:
Breast Neoplasms, Cell Line, Tumor, Chromatin Immunoprecipitation, Endodeoxyribonucleases, Escherichia coli, Female, Gene Expression Regulation, Neoplastic, Genes, Reporter, Humans, Luciferases, Mediator Complex Subunit 1, RNA Interference, RNA Polymerase II, Receptors, Estrogen, Transcription Factors, Transcription, Genetic, Tumor Suppressor Protein p53
Mol. Cell
Date: Jul. 01, 2005
Download Curated Data For This Publication
85007
Switch View:
  • Interactions 93